


Global Institute for Novel Nicotine (GINN) Email Formats
Industry Associations • London, England, United Kingdom • 1-10 Employees
Global Institute for Novel Nicotine (GINN) Email Formats
Global Institute for Novel Nicotine (GINN) uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@ginn.global), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@ginn.global | 100% |
Key Contact at Global Institute for Novel Nicotine (GINN)
Joe Sakr
Associate Director
Company overview
| Headquarters | London, England, United Kingdom |
| Website | |
| NAICS | 81391 |
| Founded | 2024 |
| Employees | 1-10 |
About Global Institute for Novel Nicotine (GINN)
The Global Institute for Novel Nicotine (GINN) is a membership-based association dedicated to advancing innovation, research, and advocacy in the field of novel nicotine products. Under the leadership of Director Shem Baldeosingh, who brings over eight years of senior leadership experience in the nicotine industry and extensive experience working with Commonwealth and national governments, GINN supports the development and adoption of reduced-risk alternatives, such as nicotine pouches and heated tobacco products, to create a safer future for consumers worldwide. At GINN, we collaborate with industry leaders, researchers, and policymakers to address regulatory challenges, promote harm reduction, and ensure responsible product development. Our commitment to collaboration and scientific integrity positions us as a trusted voice in the evolving landscape of tobacco harm reduction and nicotine innovation. Contact Us: For inquiries, reach out to our Director, Shem Baldeosingh, at info@ginn.global. What We Do: • Advocate for science-driven regulations. • Promote innovation in novel nicotine products. • Support research and education on harm reduction. • Foster collaboration among stakeholders. To learn more about our work, visit our website: ginn.global
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Global Institute for Novel Nicotine (GINN) has never raised funding before.
Frequently asked questions
4.8
40,000 users



